The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference36 articles.
1. SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models;Andreadou;Biochim. Biophys. Acta (BBA) - Mol. Basis Dis.,2020
2. Loss of 2 Akt (protein kinase B) isoforms in hematopoietic cells diminished monocyte and macrophage survival and reduces atherosclerosis in ldl receptor-null mice;Babaev;Arterioscler. Thromb. Vasc. Biol.,2019
3. Endothelial-to-Mesenchymal transition;Bischoff;Circ. Res.,2019
4. Comprehensive chemical analysis of Zhenshu Tiaozhi formula and its effect on ameliorating glucolipid metabolic disorders in diabetic rats;Cai;Biomed. Pharmacother.,2021
5. Endothelial-to-mesenchymal transition drives atherosclerosis progression;Chen;J. Clin. Invest.,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques;Journal of Ethnopharmacology;2024-04
2. Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis;BMC Complementary Medicine and Therapies;2024-01-24
3. Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA;Journal of Ethnopharmacology;2023-12
4. Fufang Zhenshu Tiaozhi Capsule Enhances Bone Formation and Safeguards against Glucocorticoid-Induced Osteoporosis through Innovative Mekk2-Mediated β-Catenin Deubiquitination;2023-09-13
5. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation;Biomedicine & Pharmacotherapy;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3